Swedish Orphan Biovitrum AB (OTCPK:BIOVF)
$ 31.38 -0.63 (-1.97%) Market Cap: 10.45 Bil Enterprise Value: 12.07 Bil PE Ratio: 31.90 PB Ratio: 3.01 GF Score: 90/100

Q4 2022 Swedish Orphan Biovitrum AB (publ) Earnings Call Transcript

Feb 08, 2023 / 12:00PM GMT
Release Date Price: $23.36 (+3.59%)
Operator

Ladies and gentlemen, welcome to the Sobi Q4 2022 report. (Operator Instructions) I will now hand over to the company.

Guido Oelkers;publ;CEO;President
Swedish Orphan Biovitrum AB

()-&

Yes. Thank you so much, and hello, everyone. This is your CEO. So we welcome to the Fourth Quarter Full Year 2022 Conference Call for Investors And Analysts.

The presentation was posted to sobi.com earlier. Let's go to slide number 2. Slide 2 has the usual safe harbor statement. Unless stated otherwise, we will be making comments that mostly relate to fourth quarter performance in 2022 at constant exchange rates and in million Swedish krona as per usual.

Please turn to Slide #3. This is the agenda where we plan to cover all key aspects of the report today. We plan to review the presentation first and then go to the Q&A until around 2:00 Swedish time. If you keep your questions short, we will try to be on until 3. (Operator Instructions)

In speaking order, I'm joined by Henrik, our CFO; Anders,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot